Trump names campaign manager and former Big Pharma lobbyist Susie Wiles as his chief of staff

11/12/2024 / By Arsenio Toledo

President-elect Donald Trump has chosen his 2024 campaign manager, Susie Wiles, as his White House Chief of Staff. Wiles is a former lobbyist for Big Pharma.

As president-elect, Trump has begun preparing candidates for his Cabinet, with Wiles being his very first pick, announced just two days after the election.

“Susie Wiles just helped me achieve one of the greatest political victories in American history, and was an integral part of both my 2016 and 2020 successful campaigns,” Trump said in a statement announcing her appointment on Thursday, Nov. 7. “Susie is tough, smart, innovative and is universally admired and respected. Susie will continue to work tirelessly to Make America Great Again.”

“It is a well-deserved honor to have Susie as the first-ever female Chief of Staff in United States History,” he added. “I have no doubt that she will make our country proud.”

Wiles is considered the “most important adviser” to Trump, with Politico even claiming that she is almost single-handedly responsible for making sure that Trump was, almost from the very beginning of the Republican Party’s primary season, the presumptive nominee and not Florida Gov. Ron DeSantis.

“There is nobody, I think, that has the wealth of information that she does. Nobody in our orbit. Nobody,” said top GOP pollster and strategist Tony Fabrizio. “She touches everything.”

“Certainly,” said former Florida GOP Rep. Carlos Curbelo. “She’s one of the most consequential people in American politics right now.”

Susie Wiles has lobbied for major Big Pharma companies

It appears that Wiles was able to gain her skill at running presidential campaigns from her decades of working as a lobbyist for Big Pharma companies. (Related: Trump’s top healthcare priority must be repealing Big Pharma’s legal immunity for vaccines.)

Liam Sturgess, writing for the blog platform of “The Kennedy Beacon” podcast, warned that Wiles’ close connections to Big Pharma pose a problem for the second Trump administration.

“Given the increasingly vocal opposition to the [Wuhan coronavirus] COVID-19 vaccination program, including among his base, why does Trump continue to demand acclaim for his role in pushing the shots through?” wrote Sturgess. “We find the answer in Susie Wiles, who appears to be the connective tissue between Trump and Big Pharma.”

Sturgess described Wiles as an individual who presents the facade of “a soft-spoken, approachable grandmother figure.” However, this image is coupled with the fact that she has “a long career specializing in political machinations.”

Since the mid-1980s, Wiles has worked relentlessly as a lobbyist for multiple corporate and political lobbying firms. One of these is the major lobbying firm Mercury Public Affairs, which Wiles became the co-chair of in February 2022.

Some of Mercury’s major Big Pharma clients include Pfizer, Johnson & Johnson, GlaxoSmithKline, Gilead Sciences and Novavax.

Mercury has also worked with major organizations that advocate mass and mandatory vaccinations, including the United Nations Foundation, the UN’s main charity organization, and Gavi: The Vaccine Alliance, also known as the Global Alliance for Vaccines and Immunization.

Through Wiles’ work with the smaller Tallahassee, Florida-based lobbying firm Ballard Partners, she also lobbied for the biotech research firm Nanobiosym.

Multiple investigations have uncovered that Mercury has had operatives that worked for both the Republican Party and the Democratic Party. Mercury has also had contracts with AmeriPac: The Fund For a Greater America, a political action committee founded by former Democratic House Majority Leader Steny Hoyer to help elect Democrats, and the nonprofit environmental group the Natural Resources Defense Council.

Watch this Nov. 7 episode of “X22 Report” discussing how Big Pharma is panicking over Donald Trump’s victory in the election.

This video is from the Sanivan channel on Brighteon.com.